EKSO
Price
$3.89
Change
+$0.09 (+2.37%)
Updated
Aug 28 closing price
Capitalization
10.16M
MBOT
Price
$4.00
Change
-$0.07 (-1.72%)
Updated
Aug 28 closing price
Capitalization
194.06M
70 days until earnings call
Interact to see
Advertisement

EKSO vs MBOT

Header iconEKSO vs MBOT Comparison
Open Charts EKSO vs MBOTBanner chart's image
Ekso Bionics Holdings
Price$3.89
Change+$0.09 (+2.37%)
Volume$25.92K
Capitalization10.16M
Microbot Medical
Price$4.00
Change-$0.07 (-1.72%)
Volume$2.14M
Capitalization194.06M
EKSO vs MBOT Comparison Chart in %
Loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKSO vs. MBOT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSO is a StrongBuy and MBOT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (EKSO: $3.89 vs. MBOT: $4.00)
Brand notoriety: EKSO and MBOT are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EKSO: 24% vs. MBOT: 97%
Market capitalization -- EKSO: $10.16M vs. MBOT: $194.06M
EKSO [@Pharmaceuticals: Other] is valued at $10.16M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $194.06M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKSO’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • EKSO’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than EKSO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKSO’s TA Score shows that 6 TA indicator(s) are bullish while MBOT’s TA Score has 6 bullish TA indicator(s).

  • EKSO’s TA Score: 6 bullish, 4 bearish.
  • MBOT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both EKSO and MBOT are a good buy in the short-term.

Price Growth

EKSO (@Pharmaceuticals: Other) experienced а +16.12% price change this week, while MBOT (@Pharmaceuticals: Other) price change was +12.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

Reported Earning Dates

MBOT is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($194M) has a higher market cap than EKSO($10.2M). MBOT YTD gains are higher at: 257.143 vs. EKSO (-57.486). EKSO has higher annual earnings (EBITDA): -9.25M vs. MBOT (-13.4M). MBOT has more cash in the bank: 32.7M vs. EKSO (5.24M). MBOT has less debt than EKSO: MBOT (149K) vs EKSO (5.39M). EKSO has higher revenues than MBOT: EKSO (14.7M) vs MBOT (0).
EKSOMBOTEKSO / MBOT
Capitalization10.2M194M5%
EBITDA-9.25M-13.4M69%
Gain YTD-57.486257.143-22%
P/E RatioN/AN/A-
Revenue14.7M0-
Total Cash5.24M32.7M16%
Total Debt5.39M149K3,618%
FUNDAMENTALS RATINGS
EKSO vs MBOT: Fundamental Ratings
EKSO
MBOT
OUTLOOK RATING
1..100
1422
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (44) in the Medical Specialties industry is in the same range as MBOT (58) in the Biotechnology industry. This means that EKSO’s stock grew similarly to MBOT’s over the last 12 months.

EKSO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that EKSO’s stock grew similarly to MBOT’s over the last 12 months.

EKSO's SMR Rating (100) in the Medical Specialties industry is in the same range as MBOT (100) in the Biotechnology industry. This means that EKSO’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for EKSO (92) in the Medical Specialties industry. This means that MBOT’s stock grew somewhat faster than EKSO’s over the last 12 months.

MBOT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EKSO (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKSOMBOT
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETRUF0.080.01
+12.10%
Etruscus Resources Corp.
JBFCF4.060.11
+2.85%
Jollibee Foods Corp.
AIVAF9.20N/A
N/A
Aviva Plc
JBPHF0.87N/A
N/A
Jacobio Pharmaceuticals Group Co Ltd.
SACQF10.06N/A
N/A
Spree Acquisition Corp. 1 Limited

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and MBOT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+2.37%
MBOT - EKSO
27%
Poorly correlated
-1.72%
ATEC - EKSO
25%
Poorly correlated
-0.93%
RVP - EKSO
24%
Poorly correlated
+1.20%
NMTC - EKSO
24%
Poorly correlated
-1.48%
TMDX - EKSO
24%
Poorly correlated
-0.56%
More